FAK overexpression is detected in various tumor types, including prostate cancer, breast cancer, lung cancer, ovarian cancer, and neck cancer, and FAK is also associated with the poor prognosis of cancer patients [12,13]. This evidence concerns the gene PTK2 and prostate carcinoma.